Welcome to our dedicated page for Purebase SEC filings (Ticker: PUBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind Purebase’s sustainable soil solutions? Most investors start with the annual report, but finding mineral reserve data, organic certification milestones, or segment margins can be tough. This SEC filings hub answers the exact questions people search, from “Purebase insider trading Form 4 transactions” to “Purebase quarterly earnings report 10-Q filing details.”
Stock Titan’s platform delivers more than raw documents. Our AI-powered summaries translate dense accounting language into plain English, turning 200-page disclosures into bite-size insights. Whether you need the Purebase annual report 10-K simplified, Purebase 8-K material events explained, or understanding Purebase SEC documents with AI, you’ll find it here with real-time EDGAR updates. Track Purebase Form 4 insider transactions real-time to spot executives buying mineral-rich land, compare season-over-season revenue in each Purebase earnings report filing analysis, or scan the Purebase proxy statement executive compensation to see how leadership incentives align with sustainable growth.
Need practical next steps? Use AI-generated bullet points to isolate cost-of-goods fluctuations tied to mining, monitor Purebase executive stock transactions Form 4 before critical soil-trial announcements, and export data for your models in seconds. All filing types—10-K, 10-Q, 8-K, S-1, and more—are covered, with notifications the moment they hit EDGAR. Complex agritech disclosures are now clear, actionable, and always up to date.
Stephen Craig Gillings, who is listed as Chief Financial Officer and a director of Purebase Corp (PUBC), filed an amended Form 4 reporting option acquisitions. The filing shows two separate stock option grants totaling 400,000 options with a $0.06 strike price, each reported as directly owned. One option line references a grant dated 12/13/2023 for 200,000 options exercisable beginning 12/11/2024 and expiring 02/06/2030. The second line reports an acquisition dated 02/06/2025 for 200,000 options exercisable beginning 02/06/2026 and expiring 02/06/2031. The form is an amendment and is signed by Mr. Gillings on 08/26/2025. All reported holdings are direct and the filing does not state any cash or other consideration beyond the $0.06 exercise price per share.